Paloma Gonzalez-Perez, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 49 | 0.830 |
Why?
|
| Myotonic Dystrophy | 1 | 2023 | 80 | 0.820 |
Why?
|
| Dystroglycans | 1 | 2020 | 62 | 0.690 |
Why?
|
| Muscle Weakness | 2 | 2020 | 415 | 0.670 |
Why?
|
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2019 | 6 | 0.660 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 393 | 0.570 |
Why?
|
| Neuromuscular Junction | 1 | 2020 | 407 | 0.560 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2016 | 211 | 0.540 |
Why?
|
| Dyslexia | 1 | 2018 | 215 | 0.530 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2016 | 56 | 0.500 |
Why?
|
| Cerebral Veins | 1 | 2016 | 159 | 0.470 |
Why?
|
| Reading | 1 | 2018 | 543 | 0.460 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2016 | 1473 | 0.430 |
Why?
|
| Fatigue | 1 | 2020 | 1557 | 0.410 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1058 | 0.390 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 1010 | 0.370 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 1321 | 0.260 |
Why?
|
| Melanoma | 1 | 2023 | 5709 | 0.230 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 3743 | 0.200 |
Why?
|
| Motor Neurons | 4 | 2016 | 872 | 0.200 |
Why?
|
| Pentosyltransferases | 1 | 2020 | 62 | 0.170 |
Why?
|
| Riboflavin | 1 | 2019 | 107 | 0.160 |
Why?
|
| Electrooculography | 1 | 2018 | 113 | 0.150 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 310 | 0.150 |
Why?
|
| Creatine Kinase | 1 | 2019 | 685 | 0.140 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 299 | 0.140 |
Why?
|
| Electromyography | 2 | 2019 | 1402 | 0.130 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 81 | 0.130 |
Why?
|
| Neuregulins | 1 | 2013 | 36 | 0.110 |
Why?
|
| Receptor, EphA4 | 1 | 2012 | 17 | 0.100 |
Why?
|
| Profilins | 1 | 2012 | 65 | 0.100 |
Why?
|
| Comprehension | 1 | 2018 | 639 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 2749 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2012 | 488 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2019 | 2126 | 0.090 |
Why?
|
| Superoxide Dismutase | 1 | 2012 | 595 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 17629 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 13427 | 0.080 |
Why?
|
| Phenotype | 2 | 2020 | 16735 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4980 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2018 | 6318 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26384 | 0.050 |
Why?
|
| Humans | 10 | 2023 | 768887 | 0.050 |
Why?
|
| Female | 6 | 2023 | 397464 | 0.050 |
Why?
|
| Mutation | 3 | 2016 | 30266 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 41800 | 0.030 |
Why?
|
| Pedigree | 2 | 2013 | 4545 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 223818 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 81892 | 0.030 |
Why?
|
| Neurites | 1 | 2016 | 390 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2012 | 63 | 0.030 |
Why?
|
| Zebrafish | 2 | 2016 | 3037 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2013 | 23652 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 910 | 0.030 |
Why?
|
| Growth Cones | 1 | 2012 | 117 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4784 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 1564 | 0.020 |
Why?
|
| Jews | 1 | 2012 | 359 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 18065 | 0.020 |
Why?
|
| Child | 1 | 2018 | 80969 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 89247 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1741 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2016 | 14485 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2129 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1608 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 1010 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 171790 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4123 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2065 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2012 | 3956 | 0.010 |
Why?
|
| Axons | 1 | 2012 | 1678 | 0.010 |
Why?
|
| Male | 3 | 2018 | 365249 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6242 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2013 | 8317 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5404 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12430 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 3671 | 0.010 |
Why?
|
| Animals | 3 | 2016 | 169408 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 19023 | 0.010 |
Why?
|
| Rats | 1 | 2012 | 23847 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 82074 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12798 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 223740 | 0.000 |
Why?
|